Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance

Overview of attention for article published in Annals of the Rheumatic Diseases, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

patent: 7 patents
facebook: 1 Facebook page

Readers on

mendeley: 159 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

Treatment of diuretic resistant heart failure patients having at least one copy of the…

Grant US-12600773-B2

United States of America

14 Apr 2026

IL-13 ANTIBODIES FOR THE TREATMENT OF PERENNIAL ALLERGIC RHINITIS

Application WO-2025128990-A1

World Intellectual Property Organisation (WIPO)

19 Jun 2025

USE OF ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF HIDRADENTITIS SUPPURATIVA (HS)

Application WO-2024187058-A1

World Intellectual Property Organisation (WIPO)

12 Sep 2024

IL-13 ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS

Application WO-2023215769-A1

World Intellectual Property Organisation (WIPO)

09 Nov 2023

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.